Nadya Wells is an experienced finance and investment professional whose passion is building bridges to facilitate increased financing for global health. In recent years, she has worked on strategy for a donor government moving into NCD programs, research with WHO on banking for health (ESG+H), community based health financing with field work in Tajikistan, and new business models for financing NTD R&D for a major pharmaceutical firm.
Her research interests are around the intersections of biomedicine and finance and she teaches at the institute in the area of Biofinance. She is currently working on the FINPHARM project, funded by the Swiss National Science Foundation, exploring the impact of Financialisation on Global Health through a series of pharmaceutical case studies where she is leading the work on anti-microbial resistance (AMR).
Prior to joining the Global Health Centre she spent over 20 years as a long-term investor in Emerging and frontier markets as a portfolio manager and governance specialist. Since 2014 she has pursued a plural career combining non-executive board roles in the financial sector in multiple countries with her academic work in Global Health. She received an MBA from INSEAD, MSc in Global Health from the University of Geneva and MA in Modern History and Modern Languages from the University of Oxford.
Wells N, Chappuis F, Beran D (2020) Spotlight on Experiences of Medicine Unavailability: Access to Medicines Challenges for NCDs and NTDs - The Contrasting Cases of Insulin and Praziquantel, Expert Review of Clinical Pharmacology.
Krech R, Kickbusch I, Franz C, Wells N (2018) Banking for health: the role of financial sector actors in investing in global health, BMJ Global Health.
Kickbusch I, Krech R, Franz C, Wells N (2018) Banking for health: opportunities in cooperation between banking and health applying innovation from other sectors, BMJ Global Health.
Borisch B, Iloegbu CA, Wells N (2018) Data, Technology, and Public Health, Public health genomics.